Astellas Pharma Inc.

4503

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-05FY2027 Q1

Revenue

2.27T JPY

YoY +16.9%

Operating Income

1845.1100M JPY

YoY +94.9%

Net Income

3649.4100M JPY

YoY +347.4%

EPS

79.2JPY

YoY +107.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

2.1兆円

1.6兆円

1.1兆円

5348.1億円

Rev: 1.3兆円Op: 1556.9億円NI: 1240.9億円

Rev: 1.5兆円Op: 1330.3億円NI: 987.1億円

Rev: 1.6兆円Op: 255.2億円NI: 170.4億円

Rev: 1.9兆円Op: 410.4億円NI: 507.5億円

Rev: 2.1兆円Op: 3826.3億円NI: 2915.3億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income47.3%

Revenue Progress6409.100M

Revenue Forecast2.2T

Net Income Progress1418.300M

Net Income Forecast300000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan